New Enterprise Associates 14, L.P. Insider Trading $SURF Surface Oncology, Inc.
Get free email notifications about insider trading for New Enterprise Associates 14, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of New Enterprise Associates 14, L.P.. New Enterprise Associates 14, L.P. is 10% Owner in MULESOFT, INC ($MULE) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in APPIAN CORP ($APPN) and 10% Owner in Mersana Therapeutics, Inc. ($MRSN) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Galera Therapeutics, Inc. ($GRTX) and 10% Owner in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Casper Sleep Inc. ($CSPR) and 10% Owner in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in IMARA Inc. ($IMRA) and 10% Owner in Oyster Point Pharma, Inc. ($OYST) and 10% Owner in Surface Oncology, Inc. ($SURF).
New Enterprise Associates 14, L.P. in Surface Oncology, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of New Enterprise Associates 14, L.P.: 10% Owner
Holdings: 2,892,877 shares
Latest Transaction: May 22 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of New Enterprise Associates 14, L.P. in Surface Oncology, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADAP, APPN, CSPR, CERC, GRTX, IMRA, LOXO, MRSN, MULE, OYST, SURF, SYBX, TCON
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 22 2020 | SURF | Surface Oncology, ... | New Enterprise Associates 14, ... | 10% Owner | Sell | S | 3.66 | 420,000 | 1,535,562 | 2,892,877 | 3.3 M to 2.9 M (-12.68 %) |
| Apr 23 2018 | SURF | Surface Oncology, ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
| Apr 23 2018 | SURF | Surface Oncology, ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
| Apr 23 2018 | SURF | Surface Oncology, ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
| Apr 23 2018 | SURF | Surface Oncology, ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
| Apr 23 2018 | SURF | Surface Oncology, ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
| Apr 23 2018 | SURF | Surface Oncology, ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Page: 1